Administrative practices and procedures; internal review of agency decisions---FDA. Direct final rule.

  • Published 1998 in Federal register


The Food and Drug Administration (FDA) is amending its regulations governing the review of agency decisions by inserting a statement that sponsors, applicants, or manufacturers of drugs (including biologics) or devices may request review of a scientific controversy by an appropriate scientific advisory panel, or an advisory committee. This action is being… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.